Literature DB >> 8811767

Use of hormone replacement therapy. May depend on whether the menopause is regarded as physiological or pathological.

K Hinshaw.   

Abstract

Mesh:

Year:  1996        PMID: 8811767      PMCID: PMC2352004          DOI: 10.1136/bmj.313.7058.686a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Women need to be fully informed about risks of hormone replacement therapy.

Authors:  E H Price; H K Little
Journal:  BMJ       Date:  1996-05-18

Review 2.  Oestrogen replacement therapy and Alzheimer's disease.

Authors:  A Paganini-Hill
Journal:  Br J Obstet Gynaecol       Date:  1996-05

3.  Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis.

Authors:  K Hunt; M Vessey; K McPherson
Journal:  Br J Obstet Gynaecol       Date:  1990-12

4.  Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.

Authors:  J L Stanford; N S Weiss; L F Voigt; J R Daling; L A Habel; M A Rossing
Journal:  JAMA       Date:  1995-07-12       Impact factor: 56.272

5.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.

Authors:  G A Colditz; S E Hankinson; D J Hunter; W C Willett; J E Manson; M J Stampfer; C Hennekens; B Rosner; F E Speizer
Journal:  N Engl J Med       Date:  1995-06-15       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.